National Institute of Allergy and Infectious Diseases Notice of Closed Meeting, 55207 [2016-19679]
Download as PDF
<![CDATA[
rmajette on DSK2TPTVN1PROD with NOTICES
Federal Register / Vol. 81, No. 160 / Thursday, August 18, 2016 / Notices
President gave certain authorities to the
PACHA for implementation of the
National HIV/AIDS Strategy for the
United States (Strategy). PACHA is
currently operating under the authority
given in Executive Order 13708, dated
September 30, 2015.
PACHA provides advice, information,
and recommendations to the Secretary
regarding programs, policies, and
research to promote effective treatment,
prevention, and cure of HIV disease and
AIDS, including considering common
co-morbidities of those infected with
HIV as needed, to promote effective HIV
prevention and treatment and quality
services to persons living with HIV
disease and AIDS.
Substantial progress has been made in
addressing the domestic HIV epidemic
since the Strategy was released in July
2010. Under Executive Order 13703, the
National HIV/AIDS Strategy for the
United States: Updated to 2020
(Updated Strategy) was released.
PACHA shall contribute to the federal
effort to improve HIV prevention and
care.
The functions of the Council are
solely advisory in nature.
The Council consists of not more than
25 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
philanthropy, marketing or business, as
well as other national leaders held in
high esteem from other sectors of
society. Council members are appointed
by the Secretary or designee, in
consultation with the White House
Office on National AIDS Policy. The
agenda for the upcoming meeting will
be posted on the AIDS.gov Web site at
www.aids.gov/pacha.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify Caroline
Talev at Caroline.Talev@hhs.gov. Due to
space constraints, pre-registration for
public attendance is advisable and can
be accomplished by contacting Caroline
Talev at Caroline.Talev@hhs.gov by
close of business on Monday, September
19, 2016. Members of the public will
have the opportunity to provide
comments at the meeting. Any
individual who wishes to participate in
the public comment session must
register with Caroline Talev at
Caroline.Talev@hhs.gov by close of
business on Monday, September 19,
2016; registration for public comment
will not be accepted by telephone.
Individuals are encouraged to provide a
VerDate Sep<11>2014
15:05 Aug 17, 2016
Jkt 238001
written statement of any public
comment(s) for accurate minute taking
purposes. Public comment will be
limited to two minutes per speaker. Any
members of the public who wish to have
printed material distributed to PACHA
members at the meeting are asked to
submit, at a minimum, 1 copy of the
material(s) to Caroline Talev, no later
than close of business on Monday,
September 19, 2016.
Dated: July 28, 2016.
B. Kaye Hayes,
Executive Director, Presidential Advisory
Council on HIV/AIDS.
[FR Doc. 2016–19660 Filed 8–17–16; 8:45 am]
BILLING CODE 4150–43–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Vaccine
Research Center Board of Scientific
Counselors, NIAID.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), title 5 U.S.C., as amended for
the review, discussion, and evaluation
of individual intramural programs and
projects conducted by the National
Institute of Allergy and Infectious
Diseases, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personnel
privacy.
Name of Committee: Vaccine Research
Center Board of Scientific Counselors, NIAID.
Date: September 8–9, 2016.
Time: 8:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health, 40
Convent Drive, Bethesda, MD 20892.
Contact Person: John R Mascola, MD,
Deputy Director, Vaccine Research Center,
NIAID, NIH, 40 Convent Drive, Bethesda, MD
20892, (301) 496–1852, jmascola@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
55207
Dated: August 12, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–19679 Filed 8–17–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection, 60-Day Comment
Request: Certificate of Confidentiality
Electronic Application System (OD)
In compliance with the
requirements of the Paperwork
Reduction Act of 1995, for opportunity
for public comment on proposed data
collection projects, the Office of
Extramural Research (OER), the
National Institutes of Health (NIH) will
continue the use of the electronic
application form for the submission of
requests to the NIH for Certificates of
Confidentiality (CoCs), which was
launched in 2015.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
SUMMARY:
To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Dr. Ann M. Hardy, NIH
Extramural Human Research Protections
Officer and Coordinator, Certificates of
Confidentiality, Office of Extramural
Programs, OER, NIH, 3701 Rockledge
Dr., Room 3002, Bethesda, MD 20892, or
call non-toll-free number (301) 435–
2690, or Email your request, including
your address to: hardyan@od.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
FOR FURTHER INFORMATION CONTACT:
Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
SUPPLEMENTARY INFORMATION:
E:\FR\FM\18AUN1.SGM
18AUN1
]]>Agencies
[Federal Register Volume 81, Number 160 (Thursday, August 18, 2016)]
[Notices]
[Page 55207]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19679]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Vaccine Research Center Board of Scientific Counselors, NIAID.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Allergy and Infectious Diseases, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personnel privacy.
Name of Committee: Vaccine Research Center Board of Scientific
Counselors, NIAID.
Date: September 8-9, 2016.
Time: 8:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, 40 Convent Drive,
Bethesda, MD 20892.
Contact Person: John R Mascola, MD, Deputy Director, Vaccine
Research Center, NIAID, NIH, 40 Convent Drive, Bethesda, MD 20892,
(301) 496-1852, jmascola@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 12, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-19679 Filed 8-17-16; 8:45 am]
BILLING CODE 4140-01-P
